Titre : Burkholderiaceae

Burkholderiaceae : Questions médicales fréquentes

Termes MeSH sélectionnés :

Exercise Test
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Burkholderiaceae : Questions médicales les plus fréquentes", "headline": "Burkholderiaceae : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Burkholderiaceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-16", "dateModified": "2025-03-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Burkholderiaceae" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Burkholderiales", "url": "https://questionsmedicales.fr/mesh/D000073556", "about": { "@type": "MedicalCondition", "name": "Burkholderiales", "code": { "@type": "MedicalCode", "code": "D000073556", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Burkholderia", "alternateName": "Burkholderia", "url": "https://questionsmedicales.fr/mesh/D019117", "about": { "@type": "MedicalCondition", "name": "Burkholderia", "code": { "@type": "MedicalCode", "code": "D019117", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Burkholderia cepacia complex", "alternateName": "Burkholderia cepacia complex", "url": "https://questionsmedicales.fr/mesh/D042602", "about": { "@type": "MedicalCondition", "name": "Burkholderia cepacia complex", "code": { "@type": "MedicalCode", "code": "D042602", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.110" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Burkholderia cenocepacia", "alternateName": "Burkholderia cenocepacia", "url": "https://questionsmedicales.fr/mesh/D057508", "about": { "@type": "MedicalCondition", "name": "Burkholderia cenocepacia", "code": { "@type": "MedicalCode", "code": "D057508", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.110.490" } } }, { "@type": "MedicalWebPage", "name": "Burkholderia cepacia", "alternateName": "Burkholderia cepacia", "url": "https://questionsmedicales.fr/mesh/D016956", "about": { "@type": "MedicalCondition", "name": "Burkholderia cepacia", "code": { "@type": "MedicalCode", "code": "D016956", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.110.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Burkholderia cenocepacia", "alternateName": "Burkholderia cenocepacia", "url": "https://questionsmedicales.fr/mesh/D057508", "about": { "@type": "MedicalCondition", "name": "Burkholderia cenocepacia", "code": { "@type": "MedicalCode", "code": "D057508", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.110.490" } } }, { "@type": "MedicalWebPage", "name": "Burkholderia cepacia", "alternateName": "Burkholderia cepacia", "url": "https://questionsmedicales.fr/mesh/D016956", "about": { "@type": "MedicalCondition", "name": "Burkholderia cepacia", "code": { "@type": "MedicalCode", "code": "D016956", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.110.500" } } }, { "@type": "MedicalWebPage", "name": "Burkholderia gladioli", "alternateName": "Burkholderia gladioli", "url": "https://questionsmedicales.fr/mesh/D042725", "about": { "@type": "MedicalCondition", "name": "Burkholderia gladioli", "code": { "@type": "MedicalCode", "code": "D042725", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.355" } } }, { "@type": "MedicalWebPage", "name": "Burkholderia mallei", "alternateName": "Burkholderia mallei", "url": "https://questionsmedicales.fr/mesh/D042726", "about": { "@type": "MedicalCondition", "name": "Burkholderia mallei", "code": { "@type": "MedicalCode", "code": "D042726", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.477" } } }, { "@type": "MedicalWebPage", "name": "Burkholderia pseudomallei", "alternateName": "Burkholderia pseudomallei", "url": "https://questionsmedicales.fr/mesh/D016957", "about": { "@type": "MedicalCondition", "name": "Burkholderia pseudomallei", "code": { "@type": "MedicalCode", "code": "D016957", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.100.600" } } } ] }, { "@type": "MedicalWebPage", "name": "Cupriavidus", "alternateName": "Cupriavidus", "url": "https://questionsmedicales.fr/mesh/D049921", "about": { "@type": "MedicalCondition", "name": "Cupriavidus", "code": { "@type": "MedicalCode", "code": "D049921", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cupriavidus necator", "alternateName": "Cupriavidus necator", "url": "https://questionsmedicales.fr/mesh/D020118", "about": { "@type": "MedicalCondition", "name": "Cupriavidus necator", "code": { "@type": "MedicalCode", "code": "D020118", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.200.200" } } } ] }, { "@type": "MedicalWebPage", "name": "Ralstonia", "alternateName": "Ralstonia", "url": "https://questionsmedicales.fr/mesh/D043367", "about": { "@type": "MedicalCondition", "name": "Ralstonia", "code": { "@type": "MedicalCode", "code": "D043367", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.600" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ralstonia pickettii", "alternateName": "Ralstonia pickettii", "url": "https://questionsmedicales.fr/mesh/D049920", "about": { "@type": "MedicalCondition", "name": "Ralstonia pickettii", "code": { "@type": "MedicalCode", "code": "D049920", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.600.600" } } }, { "@type": "MedicalWebPage", "name": "Ralstonia solanacearum", "alternateName": "Ralstonia solanacearum", "url": "https://questionsmedicales.fr/mesh/D043368", "about": { "@type": "MedicalCondition", "name": "Ralstonia solanacearum", "code": { "@type": "MedicalCode", "code": "D043368", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.075.090.688.600.750" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Burkholderiaceae", "alternateName": "Burkholderiaceae", "code": { "@type": "MedicalCode", "code": "D042521", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yusuke Takashima", "url": "https://questionsmedicales.fr/author/Yusuke%20Takashima", "affiliation": { "@type": "Organization", "name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology." } }, { "@type": "Person", "name": "Yousuke Degawa", "url": "https://questionsmedicales.fr/author/Yousuke%20Degawa", "affiliation": { "@type": "Organization", "name": "Sugadaira Research Station Mountain Science Center, University of Tsukuba." } }, { "@type": "Person", "name": "Tomoyasu Nishizawa", "url": "https://questionsmedicales.fr/author/Tomoyasu%20Nishizawa", "affiliation": { "@type": "Organization", "name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology." } }, { "@type": "Person", "name": "Hiroyuki Ohta", "url": "https://questionsmedicales.fr/author/Hiroyuki%20Ohta", "affiliation": { "@type": "Organization", "name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology." } }, { "@type": "Person", "name": "Kazuhiko Narisawa", "url": "https://questionsmedicales.fr/author/Kazuhiko%20Narisawa", "affiliation": { "@type": "Organization", "name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Prognostic value of cardiopulmonary exercise test in children with congenital heart defects.", "datePublished": "2024-08-19", "url": "https://questionsmedicales.fr/article/39160087", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/openhrt-2024-002820" } }, { "@type": "ScholarlyArticle", "name": "Exercise testing to guide safe discharge from hospital in COVID-19: a scoping review to identify candidate tests.", "datePublished": "2023-10-31", "url": "https://questionsmedicales.fr/article/37907292", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2022-068169" } }, { "@type": "ScholarlyArticle", "name": "Guidance and standard operating procedures for functional exercise testing in cystic fibrosis.", "datePublished": "2023-08-09", "url": "https://questionsmedicales.fr/article/37558263", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1183/16000617.0029-2023" } }, { "@type": "ScholarlyArticle", "name": "Cardiopulmonary exercise testing for patients with anorexia nervosa: a case-control study.", "datePublished": "2022-10-22", "url": "https://questionsmedicales.fr/article/36271269", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s40519-022-01492-6" } }, { "@type": "ScholarlyArticle", "name": "Cardiopulmonary Exercise Testing Interpretation in Athletes: What the Cardiologist Should Know.", "datePublished": "2022-10-21", "url": "https://questionsmedicales.fr/article/36368812", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ccl.2022.08.006" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Bactéries", "item": "https://questionsmedicales.fr/mesh/D001419" }, { "@type": "ListItem", "position": 3, "name": "Proteobacteria", "item": "https://questionsmedicales.fr/mesh/D020560" }, { "@type": "ListItem", "position": 4, "name": "Betaproteobacteria", "item": "https://questionsmedicales.fr/mesh/D020562" }, { "@type": "ListItem", "position": 5, "name": "Burkholderiales", "item": "https://questionsmedicales.fr/mesh/D000073556" }, { "@type": "ListItem", "position": 6, "name": "Burkholderiaceae", "item": "https://questionsmedicales.fr/mesh/D042521" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Burkholderiaceae - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Burkholderiaceae", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Burkholderiaceae", "description": "Comment diagnostiquer une infection par Burkholderiaceae ?\nQuels tests sont utilisés pour identifier Burkholderia ?\nLes symptômes aident-ils au diagnostic ?\nLes tests sérologiques sont-ils utiles ?\nQuelle est l'importance de l'antibiogramme ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Exercise+Test&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Burkholderiaceae", "description": "Quels sont les symptômes d'une infection par Burkholderia ?\nLes infections pulmonaires sont-elles fréquentes ?\nBurkholderia peut-elle causer des infections cutanées ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon le type de Burkholderia ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Exercise+Test&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Burkholderiaceae", "description": "Comment prévenir les infections par Burkholderia ?\nLes vaccinations sont-elles efficaces ?\nLes personnes à risque doivent-elles être surveillées ?\nLes mesures d'hygiène hospitalière sont-elles importantes ?\nLes équipements de protection individuelle sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Exercise+Test&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Burkholderiaceae", "description": "Quel est le traitement standard pour les infections par Burkholderia ?\nLes infections sont-elles résistantes aux antibiotiques ?\nDes traitements alternatifs existent-ils ?\nLe traitement préventif est-il possible ?\nQuelle est la durée du traitement antibiotique ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Exercise+Test&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Burkholderiaceae", "description": "Quelles sont les complications possibles d'une infection par Burkholderia ?\nLes infections peuvent-elles être mortelles ?\nY a-t-il des complications neurologiques ?\nLes infections peuvent-elles entraîner des hospitalisations prolongées ?\nQuelles sont les séquelles possibles après une infection ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Exercise+Test&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Burkholderiaceae", "description": "Quels sont les principaux facteurs de risque d'infection ?\nLes patients atteints de cysticfibrose sont-ils à risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes travailleurs de la santé sont-ils exposés ?\nLes voyages dans certaines régions augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Exercise+Test&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par Burkholderiaceae ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des cultures bactériennes et des tests de sensibilité aux antibiotiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour identifier Burkholderia ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests PCR et des séquençages génétiques sont souvent utilisés pour l'identification." } }, { "@type": "Question", "name": "Les symptômes aident-ils au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes cliniques peuvent orienter vers une infection, mais ne suffisent pas." } }, { "@type": "Question", "name": "Les tests sérologiques sont-ils utiles ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques peuvent aider, mais ne sont pas toujours fiables pour Burkholderia." } }, { "@type": "Question", "name": "Quelle est l'importance de l'antibiogramme ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'antibiogramme est crucial pour déterminer la sensibilité aux antibiotiques des souches isolées." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une infection par Burkholderia ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, toux, douleurs thoraciques et parfois des lésions cutanées." } }, { "@type": "Question", "name": "Les infections pulmonaires sont-elles fréquentes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections pulmonaires, notamment chez les patients immunodéprimés, sont courantes." } }, { "@type": "Question", "name": "Burkholderia peut-elle causer des infections cutanées ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections cutanées peuvent survenir, surtout après des blessures ou des brûlures." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes neurologiques peuvent apparaître, mais ils sont moins fréquents et souvent graves." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de Burkholderia ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon l'espèce de Burkholderia et l'état du patient." } }, { "@type": "Question", "name": "Comment prévenir les infections par Burkholderia ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut une bonne hygiène, des soins appropriés des plaies et l'évitement des contacts à risque." } }, { "@type": "Question", "name": "Les vaccinations sont-elles efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccins spécifiques contre les infections par Burkholderia." } }, { "@type": "Question", "name": "Les personnes à risque doivent-elles être surveillées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées ou avec des maladies chroniques doivent être surveillées de près." } }, { "@type": "Question", "name": "Les mesures d'hygiène hospitalière sont-elles importantes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des mesures strictes d'hygiène hospitalière sont essentielles pour prévenir les infections nosocomiales." } }, { "@type": "Question", "name": "Les équipements de protection individuelle sont-ils nécessaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'utilisation d'équipements de protection individuelle est recommandée dans les milieux à risque." } }, { "@type": "Question", "name": "Quel est le traitement standard pour les infections par Burkholderia ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard inclut des antibiotiques comme la céftazidime ou le meropenem." } }, { "@type": "Question", "name": "Les infections sont-elles résistantes aux antibiotiques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines souches de Burkholderia montrent une résistance significative aux antibiotiques." } }, { "@type": "Question", "name": "Des traitements alternatifs existent-ils ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements alternatifs peuvent inclure des combinaisons d'antibiotiques ou des thérapies ciblées." } }, { "@type": "Question", "name": "Le traitement préventif est-il possible ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement préventif peut être envisagé pour les patients à risque élevé d'infection." } }, { "@type": "Question", "name": "Quelle est la durée du traitement antibiotique ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La durée du traitement varie, mais elle est généralement de 2 à 4 semaines selon la gravité." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'une infection par Burkholderia ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des septicémies, des infections pulmonaires graves et des abcès." } }, { "@type": "Question", "name": "Les infections peuvent-elles être mortelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections par Burkholderia peuvent être mortelles, surtout chez les patients à risque." } }, { "@type": "Question", "name": "Y a-t-il des complications neurologiques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques, bien que rares, peuvent survenir, entraînant des séquelles." } }, { "@type": "Question", "name": "Les infections peuvent-elles entraîner des hospitalisations prolongées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections graves par Burkholderia peuvent nécessiter des hospitalisations prolongées." } }, { "@type": "Question", "name": "Quelles sont les séquelles possibles après une infection ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les séquelles peuvent inclure des problèmes respiratoires chroniques ou des troubles neurologiques." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'infection ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent l'immunodépression, les maladies chroniques et les traumatismes." } }, { "@type": "Question", "name": "Les patients atteints de cysticfibrose sont-ils à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients atteints de cysticfibrose sont particulièrement vulnérables aux infections par Burkholderia." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru d'infections en raison d'un système immunitaire affaibli." } }, { "@type": "Question", "name": "Les travailleurs de la santé sont-ils exposés ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les travailleurs de la santé peuvent être exposés à des souches résistantes dans les hôpitaux." } }, { "@type": "Question", "name": "Les voyages dans certaines régions augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des régions où Burkholderia est endémique peut augmenter le risque d'infection." } } ] } ] }

Sources (10000 au total)

Prognostic value of cardiopulmonary exercise test in children with congenital heart defects.

Cardiopulmonary exercise testing (CPET) has an important prognostic value in adults with different congenital heart defects (CHDs) and is a useful tool for risk stratification and clinical decision-ma... 411 CPET performed by paediatric patients with different CHDs were evaluated in this retrospective study. Medical records were reviewed to determine the presence of cardiac events. Participants were c... 411 patients with a median age at test of 12 years, 51 patients with simple CHD, 170 patients with moderate complexity CHD and 190 with high complexity CHD underwent CPET. Overall, CPET parameters wer... Reduced exercise capacity at young age is related to a higher probability of future cardiovascular events in paediatric patients with CHD. Submaximal exercise variables can be used instead when maxima...

Exercise testing to guide safe discharge from hospital in COVID-19: a scoping review to identify candidate tests.

We aimed to identify exercise tests that have been validated to support a safe discharge to home in patients with or without COVID-19.... Scoping review, using PRISMA-ScR reporting standards. Medline, PubMed, AMED, Embase, CINAHL and LitCovid databases were searched between 16 and 22 February 2021, with studies included from any publica... Short exercise tests.... Safe discharge from hospital, readmission rate, length of hospital stay, mortality. Secondary outcomes measures: safety, feasibility and reliability.... Of 1612 original records screened, 19 studies were included in the analysis. These used a variety of exercise tests in patients with chronic obstructive pulmonary disease, suspected pulmonary embolism... Further research is needed to aid clinical decision-making at discharge from hospital....

Cardiopulmonary exercise testing for patients with anorexia nervosa: a case-control study.

Patients with anorexia nervosa (AN) require appropriate nutrient therapy and physical activity management. Eating disorder treatment guidelines do not include safe, evidence-based intensity criteria f... CPX was performed with 14 female patients with AN admitted to a specialized eating disorder unit between 2015 and 2019. Their anaerobic threshold (AT) was determined by assessing their exercise tolera... The AT of the AN group (BMI: 15.7 [Mean] ± 1.8 standard deviation [SD]) was significantly lower than that of the HC group (BMI: 19.7 ± 1.8) (AN: 10.0 ± 1.8 vs. HC: 15.2 ± 3.0 ml/kg/min, P < 0.001). AT... This study showed that AT and AT-METS were lower in patients with AN than in HC. Patients with AN should be prescribed light-intensity aerobic exercise, and the current findings may help develop futur... III: Evidence obtained from case-control analytic studies....

Cardiopulmonary exercise testing in long covid shows the presence of dysautonomia or chronotropic incompetence independent of subjective exercise intolerance and fatigue.

After COVID-19 infection, 10-20% of patients suffer from varying symptoms lasting more than 12 weeks (Long COVID, LC). Exercise intolerance and fatigue are common in LC. The aim was to measure the max... Cardiopulmonary exercise test was conducted on 101 LC patients, who were admitted to exercise testing. The majority of them (86%) had been treated at home during their acute COVID-19 infection. Peak o... The measurements were performed in mean 12.7 months (SD 5.75) after COVID-19 infection in patients with exercise intolerance (group EI, 19 patients), fatigue (group F, 31 patients), their combination ... This study on LC patients with different symptoms showed that cardiopulmonary exercise capacity was in mean normal, with increased sympathetic activity in most patients. However, we identified subgrou...

Test-retest reliability of a 30-min fixed perceived effort cycling exercise.

Using exercise protocols at a fixed rating of perceived effort (RPE) is a useful method for exploring the psychophysical influences on exercise performance. However, studies that have employed this pr... Eight recreationally active cyclists completed two identical ramped incremental trials on a cycle ergometer to identify gas exchange threshold (GET). A linear regression model plotted RPE responses du... All performance and gas parameters showed excellent levels of test-retest reliability (ICCs = > .900) across both intensities. Performance, gas-related measures, and heart rate averaged over the entir... Recreationally active cyclists can reliably replicate fixed perceived effort exercise across multiple visits when RPE is aligned to physiological thresholds. Some evidence suggests that exercise at RP...

[Role of cardiopulmonary exercise test in early diagnosis of pulmonary hypertension in scleroderma patients].

Pulmonary arterial hypertension (PAH) is a severe, high mortality and progressive disease. Early diagnosis and treatment improves the prognosis. Patients with scleroderma disease presents high risk of... Prospective study of 52 consecutive patients diagnosed of scleroderma in our health area, during 2 years (2018 and 2019). All of them undergo CPET, in addition to the annual systematic screening. Sens... Fifty-two CPET were performed, of which 16 suggested PAH. Resting RHC confirmed PAH in 5 patients and exercise RHC in 7 (diagnostic sensitivity of CPET together with rest and exercise catheterization ... CPET and exercise RHC could detect PAH earlier than established screening in patients with scleroderma disease, allowing early diagnosis....

Cardiopulmonary exercise testing during follow-up after acute pulmonary embolism.

Cardiopulmonary exercise testing (CPET) may provide prognostically valuable information during follow-up after pulmonary embolism (PE). Our objective was to investigate the association of patterns and... In a prospective cohort study of unselected consecutive all-comers with PE, survivors of the index acute event underwent 3- and 12-month follow-ups, including CPET. We defined cardiopulmonary limitati... Overall, 396 patients were included. At 3 months, prevalence of cardiopulmonary limitation and deconditioning was 50.1% (34.7% mild/moderate; 15.4% severe) and 12.1%, respectively; at 12 months, it wa... Abnormal exercise capacity of cardiopulmonary origin is frequent after PE, being associated with clinical and haemodynamic impairment as well as long-term QoL reduction. CPET can be considered for sel...